Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Cumpston

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 30, 2021
Toxicity assessment of concurrent gabapentin/pregabalin administration with high-dose melphalan in autologous hematopoietic cell transplant recipientsJonathan Angus, Aaron Cumpston, Lauren Veltri, et al.
Transplantation and Cellular Therapy|April 11, 2022
Evaluation of the Pharmacokinetic Interaction Between Letermovir and Tacrolimus in Allogeneic Hematopoietic Cell Transplantation RecipientsKelsey A Marciano, Kelsea Seago, Megan Dillaman, et al.
Bone Marrow Research|May 22, 2013
Incidence and Pattern of Graft-versus-Host Disease in Patients Undergoing Allogeneic Transplantation after Nonmyeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte GlobulinLauren Veltri, Michael Regier, Aaron Cumpston, et al.
International Journal of Antimicrobial Agents|October 17, 2012
Evaluation of an alternative posaconazole prophylaxis regimen in haematological malignancy patients receiving concomitant stress ulcer prophylaxisAshley L Ross, Douglas Slain, Aaron Cumpston, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 4, 2016
Impact of intravenous magnesium infusion rate during ambulatory replacements on serum magnesium concentrations after allogeneic stem cell transplantMatthew Snyder, Alexandra Shillingburg, Michael Newton, et al.
Advances in Hematology|June 8, 2017
Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid LeukemiaBrandi Anders, Lauren Veltri, Abraham S Kanate, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 8, 2024
Efficacy of delayed pegfilgrastim administration following consolidation therapy with high-dose cytarabine (HiDAC) in acute myeloid leukemia (AML) patientsSpencer K Yingling, Joshua Francis, Kelsea Seago, et al.
Annals of Hematology|October 8, 2013
Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipientsQuoc Truong, Lauren Veltri, Abraham S Kanate, et al.
Journal of Clinical Apheresis|June 15, 2013
Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSFLubna Chaudhary, Farrukh Awan, Aaron Cumpston, et al.
Journal of Oncology|May 10, 2012
Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell MobilizationFarrukh T Awan, S Thomas Kochuparambil, David Deremer, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 30, 2021
Toxicity assessment of concurrent gabapentin/pregabalin administration with high-dose melphalan in autologous hematopoietic cell transplant recipientsJonathan Angus, Aaron Cumpston, Lauren Veltri, et al.
Transplantation and Cellular Therapy|April 11, 2022
Evaluation of the Pharmacokinetic Interaction Between Letermovir and Tacrolimus in Allogeneic Hematopoietic Cell Transplantation RecipientsKelsey A Marciano, Kelsea Seago, Megan Dillaman, et al.
Bone Marrow Research|May 22, 2013
Incidence and Pattern of Graft-versus-Host Disease in Patients Undergoing Allogeneic Transplantation after Nonmyeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte GlobulinLauren Veltri, Michael Regier, Aaron Cumpston, et al.
International Journal of Antimicrobial Agents|October 17, 2012
Evaluation of an alternative posaconazole prophylaxis regimen in haematological malignancy patients receiving concomitant stress ulcer prophylaxisAshley L Ross, Douglas Slain, Aaron Cumpston, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 4, 2016
Impact of intravenous magnesium infusion rate during ambulatory replacements on serum magnesium concentrations after allogeneic stem cell transplantMatthew Snyder, Alexandra Shillingburg, Michael Newton, et al.
Advances in Hematology|June 8, 2017
Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid LeukemiaBrandi Anders, Lauren Veltri, Abraham S Kanate, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 8, 2024
Efficacy of delayed pegfilgrastim administration following consolidation therapy with high-dose cytarabine (HiDAC) in acute myeloid leukemia (AML) patientsSpencer K Yingling, Joshua Francis, Kelsea Seago, et al.
Annals of Hematology|October 8, 2013
Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipientsQuoc Truong, Lauren Veltri, Abraham S Kanate, et al.
Journal of Clinical Apheresis|June 15, 2013
Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSFLubna Chaudhary, Farrukh Awan, Aaron Cumpston, et al.
Journal of Oncology|May 10, 2012
Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell MobilizationFarrukh T Awan, S Thomas Kochuparambil, David Deremer, et al.
Pageof 5